Is the CRO Concept "Return of the King"? WuXi AppTec aggressively attacks, leading stocks celebrate after performance!

Release the signal?!

Gelonghui FinanceMar 18 01:42 ET

Asymchem Laboratories (Tianjin) Co., Ltd.'s (SZSE:002821) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall StMar 17 21:14 ET

GTJA: Continuous iteration of anti-tumor therapies, domestic new drugs welcome breakthroughs.

GTJA focuses on products with significant differentiation advantages and leading companies in innovative segments.

Zhitong FinanceMar 16 21:18 ET

Is the breakthrough path all in AI? Chain pharmacies are facing a wave of closures and an era of low profits.

① In 2024, particularly in the second half of the year, chain pharmacies will face a large-scale wave of closures, and leading chain pharmacies will generally enter a low-profit era. ② AI is also being assigned higher expectations in helping pharmacies reduce costs and increase efficiency. ③ Publicly available large models, due to a lack of support from vertical domain data, are still insufficient to support the actual Business Operation of pharmacies.

cls.cnMar 16 02:09 ET

Asymchem Laboratories (06821.HK) held a Board of Directors meeting on March 28 to consider and approve the annual performance.

Gelonghui reported on March 14th that Asymchem Laboratories (06821.HK) announced that the Board of Directors meeting will be held on March 28, 2025 (Friday) to consider and approve the performance of the company and its subsidiaries for the year ending December 31, 2024, and its release, as well as to consider the proposal to distribute a final dividend (if any).

Gelonghui FinanceMar 14 04:42 ET

ASYMCHEM: DATE OF BOARD MEETING

HKEXMar 14 04:31 ET · Announcements